The nucleotide sequence of an 8.2-kb DNA fragment from the 5' proximal part of the chicken myb proto-oncogene spanning 1761 nucleotides upstream and 6436 nucleotides downstream from a presumed c-myb initiation codon was determined. A 3.3-kb G + C-rich region found in this sequence had also other features characterizing CpG islands, i.e. no CpG underrepresentation and lack of CpG methylation. In haematopoietic tissues c-myb mRNA synthesis starts in two major regions of the CpG island, namely 98 to 108 and 143 to 145 nucleotides upstream from the c-myb initiation codon. These two regions are in or close to the 124-bp evolutionarily conserved element located in the middle part of the CpG island. No alternative splicing of the 5' end of c-myb mRNA suggested earlier (1,2) was observed. The c-myb promoter contains neither TATA nor CAAT box-like structures at the usual positions. Instead, numerous potential Sp1 factor binding sites were found both upstream and downstream from the transcription initiation sites. Moreover, consensus v-myb protein DNA-binding sites were revealed in the promoter region and in sequences downstream from it.

Institute of Molecular Genetics Czechoslovak Academy of Sciences Prague

See more in PubMed

Nature. 1979 Oct 11;281(5731):452-5 PubMed

Oncogene Res. 1988;3(4):357-75 PubMed

J Virol. 1980 Oct;36(1):162-70 PubMed

Nucleic Acids Res. 1981 Jul 10;9(13):3015-27 PubMed

J Virol. 1981 Nov;40(2):450-5 PubMed

Proc Natl Acad Sci U S A. 1982 Apr;79(7):2194-8 PubMed

Cell. 1982 Dec;31(2 Pt 1):453-63 PubMed

Biochem Biophys Res Commun. 1989 Feb 15;158(3):737-42 PubMed

Mol Cell Biol. 1989 Feb;9(2):837-43 PubMed

Folia Biol (Praha). 1989;35(2):102-9 PubMed

Anal Biochem. 1983 Feb 15;129(1):216-23 PubMed

Methods Enzymol. 1983;100:255-66 PubMed

Exp Cell Res. 1983 Nov;149(1):151-62 PubMed

Cancer Res. 1984 Feb;44(2):442-6 PubMed

Cell. 1984 Jun;37(2):537-47 PubMed

Nature. 1984 Jul 19-25;310(5974):249-51 PubMed

Mol Cell Biol. 1984 Jul;4(7):1206-12 PubMed

Mol Cell Biol. 1982 Jun;2(6):617-24 PubMed

Proc Natl Acad Sci U S A. 1972 Jun;69(6):1408-12 PubMed

Biken J. 1974 Sep;17(3):105-16 PubMed

Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7 PubMed

EMBO J. 1985 Aug;4(8):2003-8 PubMed

Nature. 1986 Feb 13-19;319(6054):604-6 PubMed

Proc Natl Acad Sci U S A. 1986 May;83(10):3204-8 PubMed

Nature. 1986 May 15-21;321(6067):209-13 PubMed

Proc Natl Acad Sci U S A. 1986 Jul;83(13):4685-9 PubMed

Science. 1986 Jul 18;233(4761):347-51 PubMed

EMBO J. 1986 Aug;5(8):1903-11 PubMed

Mol Cell Biol. 1986 Jan;6(1):62-9 PubMed

Mol Cell Biol. 1986 Nov;6(11):3677-84 PubMed

Proc Natl Acad Sci U S A. 1986 Dec;83(24):9636-40 PubMed

Nucleic Acids Res. 1986 Dec 22;14(24):10009-26 PubMed

Folia Biol (Praha). 1987;33(1):1-10 PubMed

Anal Biochem. 1987 Apr;162(1):156-9 PubMed

EMBO J. 1987 Jun;6(6):1643-51 PubMed

Science. 1987 Sep 18;237(4821):1473-6 PubMed

J Mol Biol. 1987 Jul 20;196(2):261-82 PubMed

EMBO J. 1987 Oct;6(10):3085-90 PubMed

Nucleic Acids Symp Ser. 1987;(18):193-6 PubMed

Oncogene. 1988 Mar;2(3):267-72 PubMed

FEBS Lett. 1988 May 9;232(1):227-34 PubMed

Oncogene. 1987;1(4):395-401 PubMed

Oncogene. 1988 Jun;2(6):545-51 PubMed

Nature. 1988 Oct 27;335(6193):835-7 PubMed

Science. 1988 Dec 2;242(4883):1303-6 PubMed

Folia Biol (Praha). 1988;34(3):129-46 PubMed

Folia Biol (Praha). 1988;34(3):147-69 PubMed

Nucleic Acids Res. 1988 Dec 23;16(24):11521-30 PubMed

Methods Enzymol. 1980;65(1):499-560 PubMed

See more in PubMed

GENBANK
X14612